RBN-3143 |
| Catalog No.GC69804 |
RBN-3143 est un inhibiteur compétitif efficace de PARP14 catalysant la NAD+ avec une valeur IC50 de 4 nM. RBN-3143 inhibe l'ADP-ribosylation médiée par PARP14 et stabilise PARP14 dans les lignées cellulaires. RBN-3143 est utilisé pour la recherche sur l'inflammation pulmonaire.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2360853-16-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for RBN-3143
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for RBN-3143
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *